IMMUNIC, INC. 8-K

What Happened Immunic, Inc. (IMUX) filed an 8-K on April 10, 2026 disclosing a Retention Bonus Agreement dated April 7, 2026 with CEO Daniel Vitt. The agreement provides Mr. Vitt a $670,000 retention bonus (less withholding) payable after he remains employed through the 91st day after the company hires a new chief executive officer, or sooner in certain termination circumstances.

Key Details

• Agreement date: April 7, 2026; 8-K filed April 10, 2026.
• Retention Bonus: $670,000, paid in one lump sum on the first regular pay date after the 91st day following hire of a new CEO (the "Retention Date).
• Early payment: If the company terminates Mr. Vitt without "Cause" or he resigns for "Good Reason" before the Retention Date, the bonus is payable within five days.
• Offset and terms: If paid, the bonus will be credited against any cash severance otherwise due under Mr. Vitt’s U.S. Employment Agreement (dated Jan 1, 2026) or his Immunic AG service agreement (Dec 18, 2023). The agreement includes mutual non-disparagement and is governed by New York law.

Why It Matters This filing signals Immunic is undertaking a formal CEO search while retaining its current CEO in a senior scientific/portfolio role. The cash commitment ($670k) and the severance offset are material for investors because they affect near-term cash obligations and clarify management transition terms. The agreement reduces the risk of an unexpected leadership gap by incentivizing continuity during the search.